Ⓐ
PeptiBrief
Synthetic tripeptide

Vezugen

A synthetic Lys-Glu-Asp tripeptide promoted for vascular bioregulation, with limited and regionally concentrated evidence.

Sequence
Lys-Glu-Asp
Formula
C15H26N4O8
Molecular weight
390.39 Da

Evidence confidence

Human
2/5
Some human clinical evidence
1 citation
Animal
Not yet assessed
Trust Engine review pending.
Mechanistic
Not yet assessed
Trust Engine review pending — see editorial links below.
Editorial evidence links exist, but this category has not yet completed Trust Engine assessment.
Safety
2/5
Partially characterised safety
1 citation

Claimed uses

Mechanisms

Safety notes

Long-term safety, pharmacokinetics, interactions and product authenticity are not established.

Regulation
  • Not approved as a medicine in major regulated markets.

References

  1. The efficacy of peptide bioregulators of vessels in lower urinary tract symptoms and vasculogenic erectile dysfunction · 2014
Last reviewed
12 July 2026
Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.